Description: In this session, attendees will learn to model historical mortality rates and to forecast their possible future scenarios, using a freely available and well-tested toolkit written in open source R. The core of the toolkit is implemented in the R package StMoMo (https://CRAN.R-project.org/package=StMoMo) and enables a practitioner to derive best estimate and measurements of uncertainty using academically robust demographic and actuarial mortality projection models.

Description: Several key market trends have encouraged the development and launch of direct to consumer business models over the last few years. The presenters will look at the impact this is having on traditional business models and the potential it has to open up growth paths to target markets. They will cover several new entrants coming to market aiming to solve specific industry gaps and/or create new opportunities in distribution, risk assessment, customer engagement and the consumer buying experience.

Description: There has been significant discussion of PBR for Life Insurance, but there has also been progress in development of PBR for annuities; including VM-21, VM-22, and future VM-23. The presenters will look at the progress in PBR for annuities and what the future may hold.

Description: Since IFRS17 draft was issued in June 2019, IASB has discussed various important issues, such as the selection of B137 and the judgment to investment components. This session will be focused on the discussion and sharing of these aspects, to help understand the latest developments. At the same time, actuaries played an important role in the implementation of IFRS 17. The speaker will share the important work of actuaries in the implementation and application of IFRS 17 through the observation of the previous implementation process.

Description: "Any number of disruptions can threaten one's career path - whether it's caused by volatility in an industry, changes in the market, business strategies, an acquisition, a layoff or personal situations such as child birth or a health crisis. This panel of successful women will share their experiences with disruption, how it affected their careers, how they managed through it, and what they learned from it. No job is 100% immune from career-altering situations. Even the most successful professionals must be prepared for, confront and adjust to changes that can impact their career. Attendees will hear from women who faced a range of career-altering situations and gain insight and ideas to keep your career where you want it."

Description: The speech briefly analyzed the national reimbursement list from the perspective of health economics. The overall principle and logic behind it, and the relevant important considerations; In the construction and practical use of the national reimbursement list, it discussed the commercial insurance directory importance and enlightenment of national reimbursement list to establishment of commercial insurance directory.

Description: This presentation studies the mortality prediction performance of the Lee-Carter model.

Description: As China’s population officially ages, the government has now escalated reform of China's social security system to a national strategic level. The report of the 19th National Congress further mentioned construction of an old-age security system and social environment, painting a bright future for development of the pension industry. At the moment, development of China's pension industry is beginning a new journey. Learn about the current status and future development of pillar 2 pension, which is core to China's pension system; framework and operation management overview of Enterprise Annuity and Occupational Annuity; possible evolution paths in contribution payment methods’ investment operation models, and development of professional pension managers.

Description: The proposed session will introduce Outcome Based Risk Sharing Arrangements (“OBRSA”) between health insurance payers (“payers”, including insurance companies, health plans, sponsored employers, and government programs) and pharmaceutical manufacturers (“pharma”), and it’s intended to meet the needs of actuaries who focus on pharmacy benefits and risk sharing arrangements. The covered content will include (1) the background of OBRSAs, definitions, stakeholders, and OBRSA’s role in shifting the system from volume-based toward value-based; (2) conflicting perspectives about OBRSAs between payers and pharma (cultural and methodological); (3) identification of incentive gaps between payers and pharma, and incentive alignment between them; (4) barriers to implement OBRSAs; (5) limitations and considerations of OBRSA implementation; and (5) hypothetic OBRSA examples.

Description: The presenters will dig into the little rider that most actuaries don't spend much time thinking about. A regulator, a direct writer and a consultant will discuss their thoughts on this rider and point out areas where actuaries should focus before deeming it insignificant. Topics will include the current study underway to update the industry experience study (most recently done in 1952), underwriting considerations, interactions with other riders, benefit designs, unique issues on UL policies, tax implications and reserving considerations